Summary: A method for estimating receptor density (BrnaJ in the living human brain by positron emission to mography was exemplified by a ligand, 3-N-[IICJmethyl spiperone ([lICJNMSP ), that binds to D2 dopamine re ceptors with high affinity. The ligand binds essentially ir reversibly (i.e., with very little dissociation) to the receptors during the 2-h scanning period. Transfer con stants were estimated at steady state. In a previous ar ticle, we presented a method for the determination of k3, the rate of binding of the labeled ligand. In the present work, we varied k3 by reducing the number of available receptors with a previously administered receptor
blocking agent, haloperidol. We calculated a receptor density of 9.2 pmol g-l in the caudate nucleus of four normal volunteers, and an inhibitory constant of haloper idol of 1.4 nM by comparing tracer accumulation in the absence and the presence of the blocking agent. The values agreed with measurements of NMSP receptor density and haloperidol inhibitory potency in vitro in brain homogenates from human autopsy material. Key Words: Dopamine receptors-Human-3-N-Methyl spiperone-Positron emission tomography -Quantita tive neuroreceptor imaging.
persons and to measure the effect of drug therapy (Wagner et al. , 1983; Wong et al. , 1984a Wong et al. , , 1985a Farde et al. , 1985; Frost et al. , 1985; Inoue et al. , 1985; Samson et al. , 1985) .
Several methods have been proposed for esti mating the parameters of binding. In part, the choice of method depends on the particular proper ties of the ligand. The measurements include deter mination of the rate of binding to the receptor (k3), the degree of dissociation from the receptor (k4) , and the rate at which the ligand reaches equilibrium between the concentration of free ligand (Cr), con centration of bound ligand (Cb) , and plasma con centration (Ca) (Mintun et al., 1984; Brooks et al. , 1984) .
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In the case of the irreversibly bound radio ligand
3-N-[iiC]methylspiperone ([iiC]NMSP), Cr and Ca reach steady state during a 2-h imaging period but
Cr and Cb do not because of the irreversibility (high affinity) of the binding; hence, a separate determi nation of k3' the rate of binding to the receptor, is necessary for the ultimate calculation of the re ceptor quantity (Bmax).
In the case of ligands that rapidly dissociate from the receptor during the imaging period (low-affinity ligands), it is possible to calculate Bmax from the equilibrium distribution, provided the free ligand concentration (Cr) can be estimated for the receptor region.
In the companion article (Wong et aI., 1986a) , we present the method of estimating the binding rate of irreversibly bound (high-affinity) ligands that cannot be studied by an equilibrium method be cause tomographic scans must be of limited dura tion in humans.l
In this article, we demonstrate how it is possible to estimate the binding capacity and affinity of the labeled ligand or an unlabeled competing substance when the labeled ligand binds irreversibly to the re ceptor. Using [llC]NMSP and appropriately deter mined rate constants in the absence and presence of the inhibitor haloperidol, we determined the density (BmaJ of D2 dopamine receptors in the living human brain.
METHODS

Theory
When an irreversible accumulation of tracer is due to receptor binding in the tissue, and when the binding obeys simple receptor kinetics, then the rate of accumu lation (0') is a function of the receptor density ( B :n a J and the volume of distribution of the tracer:
where Vr is the actual volume of distribution, Vd the volume of the brain in which the tracer actually dissolves (e.g., the water volume), and k on the molecular associa tion constant ("on-rate"). The ratio between 0' and Vf is the binding rate (k3):
The ratio between the molecular dissociation (k o ff) and association rates defines the ligand's dissociation con stant:
where KD is the dissociation constant (the ratio of the rates), which is a measure of the ligand's affinity for the receptor. Ligands of the same chemical group tend to have similar association rates, the affinity varying with the dissociation. Thus, high-affinity ligands tend to have low dissociation rates and low-affinity ligands tend to have high dissociation rates. The short half-lives of posi tron-emitting radionuclides make it impossible to achieve an effective steady state in the case of high-affinity li-I "Irreversibly" implies that the ligand does not dissociate during the scanning period.
gands because the label decays before the binding reaches equilibrium.
As illustrated in the companion article (Wong et ai., 1986a In the present study, we assume that K; is either con stant or equal to K,. Thus, we can write Eq. 2 as follows:
in the presence of a competing nonradioactive ligand with a concentration of Cr. Equation 7 can be rewritten as
In the absence of a nonradioactive inhibitor (i.e., when C[ equals zero), Eq. 8 changes to
Hence, for K; constant (e.g., equal to K,), Eqs. 7 and 9 provide two equations with two unknown terms, k o n B max and K;. If the magnitude of kon for the tracer equals the magnitude of kon for the inhibitor, (k�n), then the equa tions can be rewritten as and for M, equal to zero,
where M, is the product of C, and Vd and k�ff is the product of K; and k�n'
In the present study, we solved Eqs. 10 and 11 for Bmax and K; but Eq. 10 may be used for several different con centrations of the inhibitor, as illustrated in Fig. 4 . The slope of the relationship between MJ and IIk3 expressed in Eq. 10 is k�ff Bmax and the abscissa intercept is K; Yd'
Experimental procedures
Studies were performed in normal male volunteers aged 18-38 years. Informed consent was obtained in compliance with the Johns Hopkins Clinical Investigation Committee. Each subject was screened for normality by medical history, physical exam, neuropsychological testing, electrocardiogram, and blood tests.
Each PET scan was performed in the manner described previously (Wong et a!., 1984a) and outlined in the com panion article (Wong et a!., 1986a) . The four subjects un derwent two scans. The mass of NMSP injected for each scan was 4-12 fLg total (0.06-0.17 fLg kg-1 body weight). After the first scan, a second scan, performed at least 6 h later, was preceded by an oral dose of haloperidol (5 mg in one subject, 7.5 mg in other three subjects) 4 h before the ingestion of NMSP. Serum levels of haloperidol were obtained from the time of ingestion to the end of the study and measured by gas chromatography (National Pharmacology Laboratories, Knoxville, TN, U.S.A.). The sensitivity of the assay is 1 ng ml-i. The brain-blood partition coefficient (A) of haloperidol was assumed to be the same as that of NMSP.
Regions of interest were drawn over the head of the caudate nucleus and the cerebellar cortex. The PET mea surements were recorded as microcuries per milliliter of brain and reflected the average of paired regions of the left and right sides. No recovery coefficients were ap plied. All analyses were initially acquired on a PDP 11160 peripheral data processor (DEC) and further processed on a Tektronix 4042 microcomputer and mainframe com puters that included the VAX 111780 (DEC) at the Panum Institute in Copenhagen and the IBM 4341 at the Johns Hopkins Medical Institutions.
Autopsy studies
Four brains from humans who died from nonneuro logical disease (mean age 44.5 years) were rapidly dis sected to obtain the caudate nuclei. Homogenates were incubated in Tris buffer (1 mg ml-1, 50 mM, pH 7.4) with PH]NMSP (83.4 Ci mmol-1) at 37°C for 15 min. Assays were terminated by rapid filtration through flow fiber filters.
RESULTS
U sing the method described in the companion ar ticle (Wong et aI. , 1986a) , we determined the coeffi cients and transfer and rate constants l.. , ex, 13, T, Vr, K1, k2, k3' and p for NMSP before and after oral administration of haloperidol to the same indi vidual. Results are shown in Ta ble 1. Significant de clines were observed of the net accumulation rate (ex) , the binding rate (k3), and the index of reversible binding (p), and a slight rise was observed of the volume of distribution of the tracer in caudate (Vr). Figure I shows the accumulation of labeled NMSP in caudate and cerebellum and frontal cortex in a typical human subject before and after the ingestion of haloperidol. CI. (ml g-I min-I) f3 (ml g-I) The apparent volume of distribution is a function of the normalized time integral of the radioactivity in plasma. The apparent volume of distribution was calculated by dividing the regional radioactivities recorded in brain by the radioactivity recorded in plasma and corrected for the presence of nonpene trating labeled metabolites by the method outlined in Wong et al. (1986a) .
The normalized time integral of [IIC]NMSP in plasma was computed on the basis of model-cor rected plasma radioactivites. The relationship be tween the normalized integral and real time is shown in Fig. 2 . The relationship was linear after the onset of steady state. As noted in the com panion article (Wong et aI. , 1986a, Eq. 29) , this lin earity may provide an explanation for the apparent linearity between the caudate/cerebellum and time for PET scans with prior blocking with haloperidol as well as unblocked studies. However, this lin earity between e and time is not required for the validity of the general model of this or the com panion paper.
The relationship between apparent volumes of distribution of [llC]NMSP in two brain regions (caudate nucleus and cerebellum) and the normal ized integral is shown in Fig. 3 for four normal vol unteers before and after the ingestion of haloper idol. The left panels show the relationship before the ingestion and the right panels the relationship after the ingestion of the blocking agent. The upper curves in each panel show the accumulation of ra dioactivity in caudate nucleus, the lower panels the accumulation in cerebellum. onstrating the temporal tips and cerebellar regions, basal ganglia and cortical regions, and the frontopar ietal region. All images were scaled to the same inten sity maximum and normalized for injected dose. Marked blockade of the uptake of the tracer in the basal ganglia is evident in the center scans in each row.
subjects to obtain a mean value of 1. 7 ± 0. 2 ng ml � 1 (SEM; n = 4) for all four studies. The brain concentration of haloperidol was calculated by mul tiplying the plasma concentration by the measured Abscissas: normalized time integral of plasma radioactivities (min); ordinates: apparent volumes of distribution (ml g-1). 
DISCUSSION
The kinetic behavior of NMSP as a neurore ceptor ligand can be described by the model out lined in the companion article (Wong et aI. , 1986a) . The model permitted measurements of the rate of binding of ["C]NMSP to the D2 dopamine re ceptors in the caudate nucleus in the absence and the presence of haloperidol in the living human brain.
The decline of the binding rate (k3) in the pres ence of haloperidol was used to solve the funda mental equations employed to calculate the re ceptor density (BmaJ. Several assumptions underlie the solution, including the fundamental assumption that the molecular associations of NMSP and halo peridol with the receptors are of the same magni tude in vivo. Thus, differences of KD in vitro are generally dictated by differences of koff (Seeman, 1980; P. Seeman, personal communication) . The method used in the present study yielded the product of k�ff and Bmax. To calculate Bmax, we used a value of k�ff calculated from studies in animal brain in vivo (Tewson et aI. , 1980 . , Welch et aI. , 1983 . This in vivo value of k�ff is considerably longer than published values of k�ff determined in vitro (Leysen et aI. , 1978) .
Haloperidol was given orally 4 h before the study to ensure that the drug reached a steady state in brain and plasma and thus did not influence the constancy of k3• The observation that the volumes of distribution became and remained linear func tions of the normalized time integral of radioac tivities in plasma after 20 min confirmed this as sumption.
The partition coefficient of haloperidol was as sumed to be equal to that of [IIC]NMSP. Arnett et al. (1985) actually compared levels of [ISF] haloper idol in caudate nucleus and cerebellum in female baboons and published steady-state radioactivities of the tracer in cerebellum and plasma consistent with a partition coefficient orders of magnitude above that of NMSP. The finding is surprising be cause true partition coefficients, even for very lipo philic compounds, rarely exceed unity by one order of magnitude. The reason is the high brain content of water, which is not much lower than that of plasma. We therefore decided to use the only rea sonable value for a haloperidol-like compound available to us.
Another important consideration was the partial volume effect. The estimate of k3 was influenced by the accuracy of the measured activity in caudate. As a result of the limited spatial resolution of the NeuroEcat (CTI) camera (8 mm in plane, 15 mm axial full width at half-maximum), the activity in the caudate nucleus is underestimated. The partial volume effect is less apparent initially because of the compensatory contribution from the activity in areas surrounding the caudate nucleus. At later times when the regions surrounding the basal ganglia have relatively low levels of activity, the error is greater. To estimate the magnitude of this effect on the measured value of k3, we recalculated the values of k 3 , Bmax, Kj and in a typical case, using activities scaled to correct for estimated values of recovery coefficients.2 The recalculated value of k3 in the absence of inhibitor was 14% higher, while the recalculated value of k3 in the presence of inhibitor was only 1% higher. Thus, ig noring the estimated recovery coefficients resulted in no more than a 2% overestimation of Bmax and a 14% overestimation of Kj.
Another important point is the method used to occupy receptors in order to vary k3 and permit so lution of the two equations for Bmax' The method outlined in Theory permits the use of the same or a different unlabeled ligand to compete with the la beled tracer for the receptor. The use of a lower-af finity ligand like haloperidol for inhibition shortens the time that must elapse between the ingestion of the drug and the injection of tracer [IIC]NMSP be cause of the relatively rapid equilibration between the free and bound haloperidol in the brain. If unla beled NMSP were used to occupy the receptors, the time between ingestion and the PET study would have to be increased by several hours be cause of the 10-fold higher affinity for the receptors (Seeman, 1980) . When unlabeled NMSP is co-in jected with tracer NMSP, the fraction of receptors occupied by unlabeled NMSP continues to change for a longer time and the values of k3, k4' and K; change with time [Eq. 6 in this article; Eq. 3 and 4 in Wong et al. (1986a) ].
nary estimates from phantom studies (Wong et aI., 1984b) and other a priori assumptions to estimate the recovery coefficients (RC) in the following way: For the uninhibited case, RC was initially placed at 0.9, decreasing linearly to 0.6 at 90 min after injection of the tracer. For the inhibited case, RC was initially placed at 0.95, decreasing linearly to 0.8 at 90 min after injection (approximate simulations).
The combination of a low-affinity inhibitor such as haloperidol and a high-affinity tracer ligand such as [IIC] NMSP minimizes the time needed for repeat studies while retaining a high signal-noise ratio. Lower-affinity tracers may reach equilibrium be tween free and bound tracer during the time of the PET scan but have a lower signal-noise ratio in general. As a tracer for D2 dopamine receptors, [IIC]NMSP thus has several advantages. Its total nonspecific binding ratios are relatively high com pared with other dopamine binding ligands (cau date-cerebellar ratios as high as 6-7 at 90 min), and the label IIC permits repeated studies in a short period of time.
We have described previously the striking lin earity of the caudate-cerebellar ratio as a function of time after injection of the tracer [Eq. 29 in Wong et al. (1986a) ], The slope of this regression line is a useful preliminary index (Kuhar et aI., 1978) on which to base hypotheses that justify the larger doses of neuroleptic drugs necessary to actually determine Bmax. The index is not a function only of k3 when the magnitude of k3 is not negligible com pared with that of k2 (Wong et aI., 1984a (Wong et aI., , 1986b .
Our estimate of B m a x of 9.2 pmol g-l in living human brain agrees favorably with in vitro studies of human autopsy material, including [ 3 H]NMSP examined in this study (11.2 pmol g-I), and the re sults of others using labeled spiperone (rather than NMSP) (11. 7 pmol g -I) (Seeman et aI., 1985) or [ 3 H]NMSP (9 pmol g-I) (M. Titler et al., in prepa ration).
Thus, we believe it is possible to analyze the inhi bition of the neuroreceptor binding of an essentially irreversibly binding tracer kinetically to determine the receptor density (Bma X > and the inhibitory con stant of the inhibitor (KD in the living human brain, Note added in proof: We have outlined a model that employs the measurement of [JlC]NMSP in the haloper idol blocked as well as the unblocked state. In addition to providing absolute receptor density, the model increases the sensitivity of the detection of differences in receptor densities compared to caudate/cerebellar ratios when there are high receptor densities. While we were unable to detect significant differences of receptor binding of schizophrenic patients from that of normal persons in the unblocked state (Wong et ai, 1985c) , our preliminary re sults in drug treated schizophrenic patients after haloper idol blockade suggest that D2 dopamine receptor den sities in the caudate/putamen may indeed be increased severalfold (40 pmol g-I, n = 4) compared with normal controls (9.2 pmol g-I, n = 4) as measured in vivo.
